1. Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023;402(10397):203–34. DOI: 10.1016/S0140‑6736(23)01301‑6
2. Su M, Qin XS, Li Y, Upshur R, Sullivan F, Légaré F et al. Association between medication adherence and cardiovascular outcomes in patients with both diabetes and hypertension in primary care settings in Canada: A retrospective cohort study. PLOS ONE. 2025;20(4):e0319991. DOI: 10.1371/journal.pone.0319991
3. Neeland IJ, Ross R, Després J‑P, Matsuzawa Y, Yamashita S, Shai I et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. The Lancet Diabetes & Endocrinology. 2019;7(9):715–25. DOI: 10.1016/S2213‑8587(19)30084‑1
4. Clarós A, Ciudin A, Muria J, Llull L, Mola JÀ, Pons M et al. A model based on artificial intelligence for the prediction, prevention and patient‑centred approach for non‑communicable diseases related to metabolic syndrome. European Journal of Public Health. 2025;35(4):642–9. DOI: 10.1093/eurpub/ckaf098
5. Arthanat S. Promoting Information Communication Technology Adoption and Acceptance for Aging‑in‑Place: A Randomized Controlled Trial. Journal of Applied Gerontology. 2021;40(5):471–80. DOI: 10.1177/0733464819891045
6. Суплотова Л.А., Алиева О.О., Ибрагимова Л.И. Влияние дистанционного мониторинга самоконтроля гликемии на углеводный обмен и качество жизни пациентов с сахарным диабетом 1 типа. Проблемы эндокринологии. 2025;71(1):40‑9. DOI: 10.14341/probl13535
7. Селиверстов П.В., Гриневич В.Б., Шаповалов В.В., Крюков Е.В. Повышение эффективности скрининга хронических неинфекционных заболеваний с использованием технологий на основе искусственного интеллекта. Лечащий Врач. 2024;27(4):97‑104. DOI: 10.51793/ OS.2024.27.4.014
8. Wildenbos GA, Peute L, Jaspers M. Aging barriers influencing mobile health usability for older adults: A literature based framework (MOLD‑US). International Journal of Medical Informatics. 2018;114:66–75. DOI: 10.1016/j.ijmedinf.2018.03.012
9. Glavas C, Scott D, Sood S, George ES, Daly RM, Gvozdenko E et al. Exploring the Feasibility of Digital Voice Assistants for Delivery of a Home‑Based Exercise Intervention in Older Adults With Obesity and Type 2 Diabetes Mellitus: Randomized Controlled Trial. JMIR Aging. 2024;7:e53064. DOI: 10.2196/53064
10. Mueller S, Dinges SMT, Gass F, Fegers‑Wustrow I, Treitschke J, Von Korn P et al. Telemedicine‑supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial. Nature Medicine. 2025;31(4):1203–13. DOI: 10.1038/s41591‑025‑03498‑w
11. Reddy S, Booth G, Coker‑Schwimmer M, Kugley S, Rodriguez‑Borja I, Patel SV et al. Audio‑Based Care for Managing Diabetes in Adults: A Systematic Review. Medical Care. 2025;63(2):152–63. DOI: 10.1097/MLR.0000000000002096
12. Borruel S, Moltó JF, Alpañés M, Fernández‑Durán E, Álvarez‑Blasco F, Luque‑Ramírez M et al. Surrogate Markers of Visceral Adiposity in Young Adults: Waist Circumference and Body Mass Index Are More Accurate than Waist Hip Ratio, Model of Adipose Distribution and Visceral Adiposity Index. PLoS ONE. 2014;9(12):e114112. DOI: 10.1371/journal.pone.0114112
13. Чичкова В.В., Шаповалова М.А., Чичкова М.А., Анцыферов М.Б. Применение телемедицинских технологий в терапевтическом обучении пациентов с сахарным диабетом 2 типа. Сахарный диабет. 2025;28(3):223‑30. DOI: 10.14341/DM13280
14. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(1):c332–c332. DOI: 10.1136/bmj.c332
15. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. The Lancet. 2005;366(9491):1059–62. DOI: 10.1016/S0140‑6736(05)67402‑8
16. Дедов И.И., Шестакова М.В., Майоров А.Ю., Мокрышева Н.Г., Андреева Е.Н., Безлепкина О.Б. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11‑й выпуск. Сахарный диабет. 2023;26(S2):1‑157. DOI: 10.14341/DM13042
17. Дедов И.И., Мельниченко Г.А., Шестакова М.В., Трошина Е.А., Мазурина Н.В., Шестакова Е.А. и др. Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3‑ий пересмотр (лечение морбидного ожирения у взрослых). Ожирение и метаболизм. 2018;15(1):53‑70. DOI: 10.14341/omet2018153‑70
18. Ware JE, Sherbourne CD. The MOS 36‑item short‑form health survey (SF‑36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473–83. PMID: 1593914
19. Ali Sangouni A, Abdollahi S, Mozaffari‑Khosravi H. Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double‑blind, randomized controlled trial. BMC Cardiovascular Disorders. 2022;22(1):212. DOI: 10.1186/s12872‑022‑02637‑2
20. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2. DOI: 10.2337/dc09‑1825
21. Wang R, Liu J, Fang G, Shi J, Zhang C, Huang Y. Association between visceral adiposity index and cardiovascular disease: A systematic review and meta‑analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2025;35(12):104216. DOI: 10.1016/j.numecd.2025.104216
22. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety Disorders and Cardiovascular Disease. Current Psychiatry Reports. 2016;18(11):101. DOI: 10.1007/s11920‑016‑0739‑5
23. Pal K, Dack C, Ross J, Michie S, May C, Stevenson F et al. Digital Health Interventions for Adults With Type 2 Diabetes: Qualitative Study of Patient Perspectives on Diabetes Self‑Management Education and Support. Journal of Medical Internet Research. 2018;20(2):e40. DOI: 10.2196/jmir.8439
24. Borries TM, Dunbar A, Bhukhen A, Rismany J, Kilham J, Feinn R et al. The impact of telemedicine on patient self‑management processes and clinical outcomes for patients with Types I or II Diabetes Mellitus in the United States: A scoping review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2):1353–7. DOI: 10.1016/j.dsx.2019.02.014
25. Правкина Е.А., Переверзева К.Г., Буданова И.В., Якушин С.С. Телемедицина: определение, особенности внедрения в практику, эффективность и перспективы применения в кардиологии. Наука молодых. 2023;11(3):435‑46. DOI: 10.23888/HMJ2023113435‑446